Rule2026-04657

Designation of Propionyl Chloride as a List I Chemical

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
March 10, 2026
Effective
April 9, 2026

Issuing agencies

Justice DepartmentDrug Enforcement Administration

Abstract

The Drug Enforcement Administration is finalizing the control of propionyl chloride as a list I chemical under the Controlled Substances Act (CSA). Propionyl chloride is used in the illicit manufacture of the controlled substances fentanyl, fentanyl analogues, and fentanyl-related substances, and it is important to the manufacture of these substances. This final rule subjects handlers of propionyl chloride to the chemical regulatory provisions of the CSA and its implementing regulations.

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 46 (Tuesday, March 10, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 46 (Tuesday, March 10, 2026)]
[Rules and Regulations]
[Pages 11450-11456]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-04657]



[[Page 11450]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

21 CFR Part 1310

[Docket No. DEA-1189]


Designation of Propionyl Chloride as a List I Chemical

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The Drug Enforcement Administration is finalizing the control 
of propionyl chloride as a list I chemical under the Controlled 
Substances Act (CSA). Propionyl chloride is used in the illicit 
manufacture of the controlled substances fentanyl, fentanyl analogues, 
and fentanyl-related substances, and it is important to the manufacture 
of these substances. This final rule subjects handlers of propionyl 
chloride to the chemical regulatory provisions of the CSA and its 
implementing regulations.

DATES: This rulemaking will become effective on April 9, 2026. Persons 
seeking registration must apply before April 9, 2026 to continue their 
business pending final action by DEA on their application.

FOR FURTHER INFORMATION CONTACT: Terrence L. Boos, Drug and Chemical 
Evaluation Section, Diversion Control Division, Drug Enforcement 
Administration; Telephone: (571) 362-3249.

SUPPLEMENTARY INFORMATION: The Drug Enforcement Administration (DEA) is 
extremely concerned with the recent increase in the illicit manufacture 
and distribution of fentanyl. Therefore, on October 12, 2023, DEA 
published an Advanced Notice of Proposed Rulemaking (ANPRM) soliciting 
comments on the legitimate use of propionyl chloride in industry. On 
June 3, 2025, DEA published a Notice of Proposed Rulemaking (NPRM) to 
control the precursor chemical propionyl chloride as a list I 
chemical.\1\ This rulemaking finalizes that NPRM.
---------------------------------------------------------------------------

    \1\ Designation of Propionyl Chloride as a List I Chemical, 90 
FR 23483 (June 3, 2025).
---------------------------------------------------------------------------

    This action subjects handlers of propionyl chloride to the chemical 
regulatory provisions of the Controlled Substances Act (CSA) and its 
implementing regulations. This rulemaking does not establish a 
threshold for domestic and international transactions of propionyl 
chloride. As such, all transactions involving propionyl chloride, 
regardless of size, shall be regulated and are subject to control under 
the CSA. In addition, chemical mixtures containing propionyl chloride 
are not exempt from regulatory requirements at any concentration. 
Therefore, all transactions of chemical mixtures containing any 
quantity of propionyl chloride shall be regulated pursuant to the CSA.

Legal Authority

    The CSA gives the Attorney General the authority to specify, by 
regulation, chemicals as list I chemicals.\2\ A ``list I chemical'' is 
defined as ``a chemical that is used in manufacturing a controlled 
substance in violation of [the CSA] and is important to the manufacture 
of the controlled substance.'' \3\ The current list of all listed 
chemicals is published at 21 CFR 1310.02. Pursuant to 28 CFR 0.100(b), 
the Attorney General has delegated her authority to designate list I 
chemicals to the Administrator of DEA (Administrator). DEA regulations 
set forth the process by which DEA may add a chemical as a listed 
chemical. As set forth in 21 CFR 1310.02(c), the agency may do so by 
publishing a final rule in the Federal Register following a published 
NPRM with at least 30 days for public comments.
---------------------------------------------------------------------------

    \2\ 21 U.S.C. 802(34).
    \3\ Id.
---------------------------------------------------------------------------

Background

    The clandestine manufacture of fentanyl, fentanyl analogues, and 
fentanyl-related substances remains extremely concerning as the 
distribution of illicit fentanyl, fentanyl analogues, and fentanyl-
related substances continues to drive drug-related overdose deaths in 
the United States. Fentanyl is a synthetic opioid and was first 
synthesized in Belgium in the late 1950s. Fentanyl was introduced into 
medical practice and is approved for medical practitioners in the 
United States to prescribe lawfully for anesthesia and analgesia. Yet, 
due to its pharmacological effects, fentanyl can be used as a 
substitute for heroin, oxycodone, and other opioids. Therefore, due to 
its currently accepted medical use in treatment in the United States, 
DEA controls fentanyl as a schedule II controlled substance despite its 
high potential for abuse and the possibility that abuse may lead to 
severe psychological or physical dependence.\4\ Moreover, there are a 
substantial number of fentanyl analogues and fentanyl-related 
substances that are being distributed on the illicit drug market. 
Illicit manufacturers attempt to utilize unregulated precursor 
chemicals to evade law enforcement detection and precursor chemical 
controls to manufacture fentanyl, fentanyl analogues, and fentanyl-
related substances. This strategy allows for the synthesis of a variety 
of fentanyl analogues and fentanyl-related substances by making slight 
modifications to the core fentanyl structure while maintaining the same 
synthetic methodology used to synthesize fentanyl, fentanyl analogues, 
and fentanyl-related substances.
---------------------------------------------------------------------------

    \4\ 21 U.S.C. 812(c) Schedule II(b)(6) and 21 CFR 1308.12(c).
---------------------------------------------------------------------------

    The unlawful trafficking of fentanyl, fentanyl analogues, and 
fentanyl-related substances in the United States continues to pose an 
imminent hazard to the public safety. Since 2012, fentanyl has shown a 
dramatic increase in the illicit drug supply as a single substance, in 
mixtures with other illicit drugs (i.e., heroin, cocaine, and 
methamphetamine), and in forms that mimic pharmaceutical preparations 
including prescription opiates.\5\
---------------------------------------------------------------------------

    \5\ National Drug Threat Assessment 2025, Drug Enforcement 
Administration, May 2025.
---------------------------------------------------------------------------

    DEA has noted a significant increase in overdoses and overdose 
fatalities from fentanyl, fentanyl analogues, and fentanyl-related 
substances in the United States in recent years, with a slight decrease 
in 2023. According to the Centers for Disease Control and Prevention 
(CDC), opioids, mainly synthetic opioids (which include fentanyl), are 
predominantly responsible for drug overdose deaths in recent years. 
According to CDC WONDER,\6\ drug overdose deaths involving synthetic 
opioids (excluding methadone) in the United States increased from 
36,359 in 2019 to 56,516 in 2020; 70,601 in 2021; and 73,838 in 2022 
with only a slight decrease to 72,776 in 2023; and provisionally 48,018 
in 2024.\7\ While the total number of overdose deaths have been 
declining (overdose deaths peaked in 2022 with 107,941deaths; then 
decreased to

[[Page 11451]]

105,007 in 2023; and provisionally decreased to 79,848 in 2024), 
opioids continue to be the drug class associated with the largest 
number of overdose deaths. Overdose fatalities involving synthetic 
opioids coincides with a dramatic increase in law enforcement 
encounters of fentanyl, fentanyl analogues, and fentanyl-related 
substances. According to the National Forensic Laboratory Information 
System (NFLIS-Drug),\8\ reports from forensic laboratories of drug 
items containing fentanyl, fentanyl analogues, and fentanyl-related 
substances increased dramatically since 2016, as shown in Table 1 (2025 
data is still being reported).
---------------------------------------------------------------------------

    \6\ Centers for Disease Control and Prevention, National Center 
for Health Statistics. National Vital Statistics System, Provisional 
Mortality on CDC WONDER Online Database. Data are from the final 
Multiple Cause of Death Files, 2018-2024, and from provisional data 
for years 2024-2025, as compiled from data provided by the 57 vital 
statistics jurisdictions through the Vital Statistics Cooperative 
Program. Accessed at <a href="http://wonder.cdc.gov/mcd-icd10-provisional.html">http://wonder.cdc.gov/mcd-icd10-provisional.html</a> on January 27, 2026.
    \7\ Provisional counts in CDC Wonder are the counts of overdose 
deaths prior to being finalized for a calendar year. Provisional 
counts of deaths are underestimated relative to final counts. This 
is due to the many steps involved in reporting death certificate 
data. When a death occurs, a certifier (e.g. physician, medical 
examiner or coroner) will complete the death certificate with the 
underlying cause of death and any contributing causes of death. In 
some cases, laboratory tests or autopsy results may be required to 
determine the cause of death.
    \8\ The National Forensic Laboratory Information System (NFLIS) 
represents an important resource in monitoring illicit drug 
trafficking, including the diversion of legally manufactured 
pharmaceuticals into illegal markets. NFLIS-Drug is a national 
forensic laboratory reporting system that systematically collects 
results from drug chemistry analyses conducted by Federal, State and 
local forensic laboratories in the United States. While NFLIS-Drug 
data is not direct evidence of abuse, it can lead to an inference 
that a drug has been diverted and abused. See Schedules of 
Controlled Substances: Placement of Carisoprodol Into Schedule IV, 
76 FR 77330, 77332 (Dec. 12, 2011). NFLIS-Drug data was queried on 
January 8, 2026; *2025 data is still reporting.

                                 Table 1--Annual Reports of Fentanyl and Select Fentanyl Analogues and Fentanyl-Related Substances Identified in Drug Encounters
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                             Year                                   2016         2017         2018         2019         2020         2021         2022         2023         2024        2025 *
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Annual Fentanyl Reports.......................................       37,158       61,648       90,017      108,231      126,483      166,718      177,227      183,009      154,015       89,003
Annual Reports of select fentanyl analogues and fentanyl-             7,625       22,072       16,163       20,935        8,005       26,691       30,978       21,511       20,205        7,616
 related substances...........................................
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Role of Propionyl Chloride in the Synthesis of Fentanyl

    Fentanyl, fentanyl analogues, and fentanyl-related substances are 
not naturally occurring substances. As such, the manufacture of these 
substances requires them to be produced through synthetic organic 
chemistry. Synthetic organic chemistry is the process in which a new 
organic molecule is created through one chemical reaction or a series 
of chemical reactions, which involve precursor chemicals. Through 
chemical reactions, the chemical structures of precursor chemicals are 
modified in a desired fashion. These chemical reaction sequences, also 
known as synthetic pathways, are designed to create a desired 
substance. Several synthetic pathways to fentanyl, fentanyl analogues, 
and fentanyl-related substances have been identified in clandestine 
laboratory settings; these include the original ``Janssen method,'' the 
``Siegfried method,'' and the ``Gupta method.'' In response to the 
illicit manufacture of fentanyl, fentanyl analogues, and fentanyl-
related substances using these methods, DEA controlled N-phenethyl-4-
piperidone (NPP); \9\ N-(1-benzylpiperidin-4-yl)-N-phenylpropionamide 
(benzylfentanyl) and its salts; \10\ N-phenylpiperidin-4-amine (4-
anilinopiperidine) including its amides, halides, carbamates, salts, 
and any combination thereof; \11\ and 4-piperidone (piperidin-4-one) 
including its acetals, amides, carbamates, salts, and salts of acetals, 
amides, and carbamates, and any combination thereof \12\ as list I 
chemicals. DEA also controls 4-anilino-N-phenethylpiperidine (ANPP) 
\13\ and N-phenyl-N-(piperidin-4-yl)propionamide (norfentanyl) \14\ as 
schedule II immediate precursors to fentanyl under the CSA.
---------------------------------------------------------------------------

    \9\ Control of a Chemical Precursor Used in the Illicit 
Manufacture of Fentanyl as a List I Chemical, 72 FR 20039 (Apr. 23, 
2007).
    \10\ Designation of Benzylfentanyl and 4-Anilinopiperidine, 
Precursor Chemicals Used in the Illicit Manufacture of Fentanyl, as 
List I Chemicals, 85 FR 20822 (Apr. 15, 2020).
    \11\ Designation of Benzylfentanyl and 4-Anilinopiperidine, 
Precursor Chemicals Used in the Illicit Manufacture of Fentanyl, as 
List I Chemicals, 85 FR 20822 (Apr. 15, 2020).); See Also 
Designation of Halides of 4-Anilinopiperidine as List 1 Chemicals, 
88 FR 74352 (Oct. 31, 2023).
    \12\ Designation of 4-Piperidone as a List I Chemical, 88 FR 
21902-21910 (Apr. 12, 2023).
    \13\ Control of Immediate Precursor Used in the Illicit 
Manufacture of Fentanyl as a Schedule II Controlled Substance, 75 FR 
37295 (June 29, 2010).
    \14\ Control of the Immediate Precursor Norfentanyl Used in the 
Illicit Manufacture of Fentanyl as a Schedule II Controlled 
Substance, 85 FR 21320 (Apr. 17, 2020).
---------------------------------------------------------------------------

Propionyl Chloride

    The original published synthetic pathway to fentanyl, known as the 
Janssen method, involves the list I chemical benzylfentanyl and 
schedule II immediate precursor norfentanyl. In this synthetic pathway, 
benzylfentanyl, a list I chemical under the CSA,\15\ is synthesized by 
reacting propionyl chloride with 4-anilino-1-benzylpiperidine, which is 
then converted to norfentanyl, the schedule II immediate precursor to 
fentanyl in this synthetic pathway.\16\ Norfentanyl is then subjected 
to one simple chemical reaction to complete the synthesis of fentanyl. 
This synthetic pathway can also be easily modified to produce fentanyl 
analogues and fentanyl-related substances. Propionyl chloride also 
serves as a precursor chemical in the Siegfried method. In this 
synthetic pathway, propionyl chloride is reacted with ANPP,\17\ the 
schedule II immediate precursor to fentanyl in the Siegfried method, to 
complete the synthesis of fentanyl. This synthetic pathway can also be 
easily modified to produce fentanyl analogues and fentanyl-related 
substances. In addition to the Janssen and Siegfried methods, 
clandestine manufacturers are using other methods to synthesize 
fentanyl, one of which is known as the Gupta method. In this synthetic 
pathway, 4-piperidone, a list I chemical under the CSA, is used to 
synthesize 4-anilinopiperidine, another list I chemical under the 
CSA,\18\ which serves as an alternative precursor chemical to NPP, a 
list I chemical, in the synthesis of ANPP, a schedule II immediate 
precursor to fentanyl albeit through a different synthetic process. The 
resulting ANPP is reacted with propionyl chloride to manufacture the 
schedule II controlled substance, fentanyl. This synthetic pathway can 
also be easily modified to produce fentanyl analogues and fentanyl-
related substances.
---------------------------------------------------------------------------

    \15\ See footnote 10.
    \16\ See footnote 13.
    \17\ See footnote 12.
    \18\ Designation of Benzylfentanyl and 4-Anilinopiperidine, 
Precursor Chemicals Used in the Illicit Manufacture of Fentanyl, as 
List I Chemicals, 85 FR 20822 (May 15, 2020).
---------------------------------------------------------------------------

    Propionyl chloride is attractive to illicit manufacturers because 
there is a lack of regulations on this chemical, it

[[Page 11452]]

is readily available from chemical suppliers, and it can be easily used 
in many known synthetic pathways used for the illicit manufacture of 
fentanyl, fentanyl analogues, and fentanyl-related substances.

Comments Received in Response to the NPRM

    In response to the June 3, 2025 NPRM, DEA received one comment in 
opposition to the control of propionyl chloride as a list I chemical. 
The commenter cited four areas of concern relating to the control of 
propionyl chloride.
    Comment: The first concern the commenter raised was that 
controlling propionyl chloride as a list I chemical would 
disproportionately harm legitimate industries, specifically the 
pharmaceutical industry, the agrochemical industry, and other 
industries using it in their applications. The commenter mentioned 
propionyl chloride is used to synthesize vital medicines, it is an 
intermediate for crop protection agents, and can be used to produce 
dyes, textiles, and other products. The commenter also mentioned that 
even though norfentanyl is an immediate precursor to fentanyl, it was 
only controlled as a list II chemical, which is in stark contrast to 
what is being proposed for the control of propionyl chloride in list I.
    DEA Response: DEA appreciates the commenter's concern for the 
industries that may be impacted by the control of propionyl chloride as 
a list I chemical. To properly assess the potential effects of 
controlling propionyl chloride, DEA published both an ANPRM and the 
NPRM. These two publications requested information from industries and 
allowed for any interested persons to comment with their concerns.
    DEA is aware that propionyl chloride may be used as an intermediate 
in several industrial processes, including but not limited to the 
synthesis of dyes, pharmaceuticals (including fentanyl), and 
agricultural products. Designating propionyl chloride as a list I 
chemical does not preclude the use of propionyl chloride for end users 
(i.e., those using it as an intermediate chemical or in chemical 
synthesis). DEA registration for list I chemicals is only for those who 
are manufacturing, distributing, importing, or exporting list I 
chemicals. It is not required for those doing synthesis, unless they 
are also participating in one of the forementioned activities that 
require registration. Therefore, unless the user is also manufacturing, 
distributing, importing, or exporting propionyl chloride, this action 
will not affect industries that may be using propionyl chloride as an 
intermediate in synthesis. Any potential burdens on industry are 
outweighed by the public health and public safety benefits of listing 
propionyl chloride.
    In regard to controlling propionyl chloride in list I compared to 
the placement of norfentanyl, norfentanyl is controlled in schedule II 
of the CSA as an immediate precursor to fentanyl. Requirements for 
controlled substances in schedules I-V of the CSA,\19\ including 
immediate precursors in schedule II, are more restrictive than that of 
chemicals listed in list I or list II of CSA.\20\ Controlling propionyl 
chloride in list I would only require those who manufacture, 
distribute, import, or export propionyl chloride to register with DEA 
and maintain records. End users of propionyl chloride, unless they are 
engaged in one of the previous mentioned activities, would not be 
required to register with DEA. Therefore, industries who may be using 
propionyl chloride in legitimate industries will still be able to use 
propionyl chloride for research and industrial purposes and may not be 
required to register with DEA for the use of this chemical.
---------------------------------------------------------------------------

    \19\ 21 CFR 1301-1308; 21 CFR 1311-1312.
    \20\ 21 CFR 1309-1310; 21 CFR 1313.
---------------------------------------------------------------------------

    Comment: The commenter next voiced concern that this action exceeds 
DEA's authority and harms the U.S. economy. The commenter concluded 
that the United States is a net importer of propionyl chloride, and, 
therefore, DEA is attempting to regulate foreign commerce, which is an 
authority delegated exclusively to Congress.
    DEA Response: DEA appreciates the commenter's concerns. In the CSA, 
Congress authorized the Attorney General to specify, by regulation, 
chemicals as list I chemicals.\21\ This authority has been delegated to 
the Administrator of DEA,\22\ and DEA regulations address how DEA may 
add and regulate a chemical as a list I chemical, including the 
importation of that chemical.\23\ Listing a chemical in the CSA does 
not regulate foreign commerce.
---------------------------------------------------------------------------

    \21\ 21 U.S.C. 802(34).
    \22\ 28 CFR 0.100(b).
    \23\ See, e.g., 21 CFR 1310.02(c) (adding a chemical); 21 CFR 
1313.12-.17 (importation of listed chemicals).
---------------------------------------------------------------------------

    Comment: The commenter claims that DEA's regulatory strategy is 
ineffective and counterproductive.
    DEA Response: DEA is concerned with the abuse of illicitly 
manufactured fentanyl in the United States and believes this rule will 
help control the illicit manufacture of fentanyl.
    Comment: Finally, the commenter claims that DEA's history 
undermines trust in its motives. Specifically, the commenter stated 
that DEA has a long and documented history of misconduct that calls 
into question its judgment and motives.
    DEA Response: The comment about having trust in DEA's motives is 
outside the scope of this rule.

Chemical Mixtures of Propionyl Chloride

    Under the rulemaking, chemical mixtures containing propionyl 
chloride are not exempt from regulatory requirements at any 
concentration, unless an application for exemption of a chemical 
mixture is submitted by a propionyl chloride manufacturer and the 
application is reviewed and accepted by DEA under 21 CFR 1310.13. The 
control of chemical mixtures containing any amount of propionyl 
chloride is necessary to prevent the extraction, isolation, and use of 
propionyl chloride in the illicit manufacture of fentanyl. This rule 
modifies the Table of Concentration Limits in 21 CFR 1310.12(c) to 
reflect the fact that chemical mixtures containing any amount of 
propionyl chloride are subject to the CSA chemical control provisions.

Application Process for Exemption of Chemical Mixtures

    DEA has implemented an application process to exempt mixtures from 
the requirements of the CSA and its implementing regulations.\24\ 
Manufacturers may apply for an automatic exemption for those mixtures 
that do not meet the criteria set forth in 21 CFR 1310.12(d). Pursuant 
to 21 CFR 1310.13(a), DEA may grant an exemption of a chemical mixture, 
by publishing a final rule in the Federal Register, if DEA determines 
that: (1) the mixture is formulated in such a way that it cannot be 
easily used in the illicit production of a controlled substance, and 
(2) the listed chemical or chemicals cannot be readily recovered.
---------------------------------------------------------------------------

    \24\ 21 CFR 1310.13 specifies that this chemical mixture is a 
chemical mixture consisting of two or more chemical components, at 
least one of which is a list I or list II chemical. See also 21 CFR 
1300.02 (defining the term ``chemical mixture'').
---------------------------------------------------------------------------

Requirements for Handling List I Chemicals

    This final rule subjects propionyl chloride to all the regulatory 
controls and administrative, civil, and criminal sanctions applicable 
to the manufacture, distribution, importing, and exporting of list I 
chemicals. Upon the effective date of this rule, persons handling 
propionyl

[[Page 11453]]

chloride, including regulated chemical mixtures containing propionyl 
chloride, will be required to comply with list I chemical regulations, 
including the following:
    1. Registration. Any person who manufactures, distributes, imports, 
or exports propionyl chloride, including chemical mixtures containing 
propionyl chloride, or proposes to engage in the manufacture, 
distribution, importation, or exportation of propionyl chloride, 
including chemical mixtures containing propionyl chloride, must obtain 
a registration pursuant to 21 U.S.C. 822, 823, 957, and 958. 
Regulations describing registration for list I chemical handlers are 
set forth in 21 CFR part 1309. DEA regulations require separate 
registrations for manufacturing, distributing, importing, and exporting 
of list I chemicals.\25\ Further, a separate registration is required 
for each principal place of business at one general physical location 
where list I chemicals are manufactured, distributed, imported, or 
exported by a person.\26\
---------------------------------------------------------------------------

    \25\ 21 CFR 1309.21.
    \26\ 21 U.S.C. 822(e)(1) and 21 CFR 1309.23(a).
---------------------------------------------------------------------------

    DEA notes that under the CSA, ``warehousemen'' are not required to 
register and may lawfully possess list I chemicals, if the possession 
of those chemicals is in the usual course of business or employment. 
Under DEA implementing regulations, the warehouse in question must 
receive the list I chemical from a DEA registrant and shall only 
distribute the list I chemical back to the DEA registrant and 
registered location from which it was received. A warehouse that 
distributes list I chemicals to persons other than the registrant and 
registered location from which they were obtained is conducting 
distribution activities and is required to register as such.\27\
---------------------------------------------------------------------------

    \27\ 21 U.S.C. 822(a)(1).
---------------------------------------------------------------------------

    Upon the effective date of this final rule, any person 
manufacturing, distributing, importing, or exporting propionyl chloride 
or a chemical mixture containing propionyl chloride will become subject 
to the registration requirement under the CSA. DEA recognizes, however, 
that it is not possible for persons who are subject to the registration 
requirements to immediately complete and submit an application for 
registration, and for DEA to immediately issue registrations for those 
activities. Therefore, to allow any continued legitimate commerce in 
propionyl chloride or a chemical mixture containing propionyl chloride, 
DEA is establishing in 21 CFR 1310.09, a temporary exemption from the 
registration requirement for persons desiring to engage in activities 
with propionyl chloride or a chemical mixture containing propionyl 
chloride, provided that DEA receives a properly completed application 
for registration or application for exemption of a chemical mixture 
under 21 CFR 1310.13 on or before the effective date of this final 
rule. The temporary exemption for such persons will remain in effect 
until DEA takes final action on their application for registration or 
application for exemption of a chemical mixture.
    The temporary exemption applies solely to the registration 
requirement; all other chemical control requirements, including 
recordkeeping and reporting, will be effective on the effective date of 
the final rule. This is necessary because a delay in regulating these 
transactions could result in increased diversion of chemicals desirable 
to drug traffickers.
    Additionally, the temporary exemption for registration does not 
suspend applicable federal criminal laws relating to propionyl 
chloride, nor does it supersede State or local laws or regulations. All 
handlers of propionyl chloride must comply with applicable State and 
local requirements in addition to the CSA regulatory controls.
    2. Records and Reports. Every DEA registrant must maintain records 
and submit reports with respect to propionyl chloride pursuant to 21 
U.S.C. 830 and in accordance with 21 CFR 1310.04 and 1310.05. Pursuant 
to 21 CFR 1310.04, a record must be kept for two years after the date 
of a transaction involving a listed chemical, provided the transaction 
is a regulated transaction.
    Each regulated bulk manufacturer of a listed chemical must submit 
manufacturing, inventory, and use data on an annual basis. Existing 
standard industry reports containing the required information are 
acceptable, provided the information is separate or readily retrievable 
from the report.\28\
---------------------------------------------------------------------------

    \28\ 21 CFR 1310.05(d).
---------------------------------------------------------------------------

    The CSA and its implementing regulations require that each 
regulated person must report to DEA any regulated transaction involving 
an extraordinary quantity of a listed chemical, an uncommon method of 
payment or delivery, or any other circumstance that the regulated 
person believes may indicate that a listed chemical will be used in 
violation of subchapter I of the CSA. In addition, regulated persons 
must report any proposed regulated transaction with a person whose 
description or other identifying characteristics DEA has previously 
furnished to the regulated person, any unusual or excessive loss or 
disappearance of a listed chemical under the control of the regulated 
person, and any in-transit loss in which the regulated person is the 
supplier.\29\
---------------------------------------------------------------------------

    \29\ 21 U.S.C. 830(b) and 21 CFR 1310.05(a) and (b).
---------------------------------------------------------------------------

    3. Importation and Exportation. All importation and exportation of 
propionyl chloride or a chemical mixture containing propionyl chloride 
must be done in compliance with 21 U.S.C. 957, 958, and 971 and in 
accordance with 21 CFR part 1313.
    4. Security. All applicants and registrants must provide effective 
controls against theft and diversion of list I chemicals in accordance 
with 21 CFR 1309.71-1309.73.
    5. Administrative Inspection. Places, including factories, 
warehouses, or other establishments and conveyances, where registrants 
or other regulated persons may lawfully hold, manufacture, distribute, 
or otherwise dispose of a list I chemical or where records relating to 
those activities are maintained, are controlled premises as defined in 
21 U.S.C. 880(a) and 21 CFR 1316.02(c). The CSA allows for 
administrative inspections of these controlled premises as provided in 
21 CFR part 1316, subpart A. 21 U.S.C. 880.
    6. Liability. Any activity involving propionyl chloride not 
authorized by, or in violation of, the CSA, would be unlawful, and 
would subject the person to administrative, civil, and/or criminal 
action.

Regulatory Analyses

Executive Orders 12866, 13563, 14192, and 14294

    This final rule has been drafted and reviewed in accordance with 
Executive Order (E.O.) 12866, ``Regulatory Planning and Review,'' 
section 1(b), Principles of Regulation and E.O. 13563, ``Improving 
Regulation and Regulatory Review,'' section 1(b), General Principles of 
Regulation. DEA scheduling actions are not subject to either E.O. 
14192, Unleashing Prosperity Through Deregulation, or E.O. 14294, 
Fighting Overcriminalization in Federal Regulations.
    Section 3(f) of E.O. 12866 classifies a ``significant regulatory 
action,'' requiring review by the Office of Management and Budget 
(OMB), as any regulatory action that is likely to result in a rule that 
may: (1) have an annual effect on the economy of $100 million or more 
or adversely affect in a material way the economy, a sector of the 
economy, productivity, competition, jobs, the environment, public 
health or safety, or state, local, or tribal

[[Page 11454]]

governments or communities; (2) create a serious inconsistency or 
otherwise interfere with an action taken or planned by another agency; 
(3) materially alter the budgetary impact of entitlements, grants, user 
fees, or loan programs or the rights and obligations of recipients 
thereof; or (4) raise novel legal or policy issues arising out of legal 
mandates, the President's priorities, or the principles set forth in 
the E.O.
    DEA finds that propionyl chloride is used in the illicit 
manufacture of the controlled substances of fentanyl, fentanyl 
analogues, and fentanyl-related substances, and is important to the 
manufacture of these substances. The replacement chemical for propionyl 
chloride in the respective pathways is already a list I chemical. This 
final rule subjects handlers of propionyl chloride to the chemical 
regulatory provisions of the CSA and its implementing regulations. This 
final rule does not establish a threshold for domestic and 
international transactions of propionyl chloride. As such, all 
transactions of propionyl chloride, regardless of size, shall be 
regulated. In addition, chemical mixtures containing propionyl chloride 
are not exempt from regulatory requirements at any concentration. 
Therefore, all transactions of chemical mixtures containing any 
quantity of propionyl chloride shall be regulated pursuant to the CSA. 
Propionyl chloride will be subject to all of the regulatory controls 
and administrative, civil, and criminal sanctions applicable to the 
manufacture, distribution, importing, and exporting of list I 
chemicals.
    DEA evaluated the cost of this final rule. Due to many unknowns, 
DEA is unable to provide an estimated cost of this final rule; however, 
based on DEA's analysis, the Office of Information and Regulatory 
Affairs has determined that this final rule is not economically 
significant under section 3(f)(1) of E.O. 12866.

Costs

    Propionyl chloride is used for the legitimate manufacturing of 
pharmaceutical fentanyl as well as clandestinely synthesized illicit 
fentanyl. DEA has searched information in the public domain for 
legitimate uses of propionyl chloride and has documented that propionyl 
chloride may be used as an intermediary chemical in several industries, 
including the production of fentanyl. However, this rule would only 
impose regulations on those who manufacture, distribute, import, or 
export propionyl chloride and not end users who are using the chemical 
as an intermediate.
    The primary costs associated with this rule would be the annual 
registration fee for list I chemicals ($3,699 for manufacturers and 
$1,850 for distributors, importers, and exporters). DEA has identified 
20 domestic distributors of propionyl chloride. Three are already 
registered to handle list I chemicals, and this rule will not have 
impacts on their operations. The remaining distributors will need to 
register with DEA and employ security and handling processes to 
continue supplying propionyl chloride. For the nonregistered suppliers, 
it is difficult to estimate the amount of propionyl chloride that they 
distribute. It is also common for these chemical distributors to have 
items in their catalog while not actually having any material level of 
sales. Hence, DEA expects the quantities of propionyl chloride 
distributed by nonregistered distributors to be much smaller compared 
to the registered distributors. These distributors are expected to 
choose the least cost option, and stop selling propionyl chloride, 
rather than incur the registration cost. DEA expects that the cost of 
foregone sales will be small; and thus, the cost of this rule is 
minimal. DEA requested public comments regarding this estimate, however 
no public comment was received during the notice and comment period 
regarding the costs to industry.

Benefits

    Controlling propionyl chloride is expected to prevent, curtail, and 
limit the unlawful manufacture and distribution of the controlled 
substance, fentanyl, as well as fentanyl analogues and fentanyl-related 
substances. As a list I chemical, handling of propionyl chloride 
requires registration with DEA and various controls and monitoring as 
required by the CSA. This rule is also expected to assist in preventing 
the possible theft or diversion of propionyl chloride from any 
legitimate firms. DEA also believes control is necessary to prevent 
unscrupulous chemists from synthesizing propionyl chloride and selling 
it (as an unregulated material) through the internet and other 
channels, to individuals who may wish to acquire unregulated 
intermediary chemicals for the purpose of illicitly manufacturing 
fentanyl, fentanyl analogues, and fentanyl-related substances.
    In summary, DEA conducted a qualitative analysis of this final 
rule. DEA believes any manufacturer or distributor that uses propionyl 
chloride for legitimate pharmaceutical fentanyl production already 
would be registered with DEA and have all security and other handling 
processes in place, such that this regulation would result in minimal 
cost to those entities. Therefore, any potential cost as a result of 
this regulation is minimal.

Executive Order 12988, Civil Justice Reform

    This rulemaking meets the applicable standards set forth in 
sections 3(a) and 3(b)(2) of E.O. 12988 Civil Justice Reform to 
eliminate drafting errors and ambiguity, minimize litigation, provide a 
clear legal standard for affected conduct, and promote simplification 
and burden reduction.

Executive Order 13132, Federalism

    This rulemaking does not have federalism implications warranting 
the application of E.O. 13132. The final rule does not have substantial 
direct effects on the States, on the relationship between the national 
Government and the States, or the distribution of power and 
responsibilities among the various levels of government.

Executive Order 13175, Consultation and Coordination With Indian Tribal 
Governments

    This rulemaking does not have tribal implications warranting the 
application of E.O. 13175. This final rule does not have substantial 
direct effects on one or more Indian tribes, on the relationship 
between the Federal government and Indian tribes, or on the 
distribution of power and responsibilities between the Federal 
government and Indian tribes.

Regulatory Flexibility Act

    The Administrator, in accordance with the Regulatory Flexibility 
Act, 5 U.S.C. 601-612, has reviewed this rule and by approving it, 
certifies that it will not have a significant economic impact on a 
substantial number of small entities.
    As discussed above, with this rulemaking, propionyl chloride and 
chemical mixtures containing propionyl chloride will be subject to all 
of the regulatory controls and administrative, civil, and criminal 
sanctions applicable to the manufacture, distribution, importing, and 
exporting of list I chemicals. This rulemaking will affect all business 
activities that handle propionyl chloride including manufacturers, 
distributors, importers, and exporters. DEA identified 20 domestic 
suppliers, 17 (85 percent) of which are not registered with DEA to 
handle list I chemicals. All non-registered entities will be affected 
by this rule and are small entities based on Small Business 
Administration classification for Other Chemical and

[[Page 11455]]

Allied Products Merchant Wholesalers (NAICS classification code 
424690).\30\
---------------------------------------------------------------------------

    \30\ U.S. Small Business Administration, Table of size 
standards, Version March 2023, Effective: March 17, 2023, <a href="https://www.sba.gov/sites/sbagov/files/2023-">https://www.sba.gov/sites/sbagov/files/2023-</a>.
---------------------------------------------------------------------------

    There are 8,804 small entities under 424690 Other Chemical and 
Allied Products Merchant Wholesalers.\31\ The number of small entities 
affected by this final rule is 0.19 percent of all the small businesses 
in this industry.\32\ Based on these factors, DEA projects that this 
rule will not result in a significant economic impact on a substantial 
number of small entities.
---------------------------------------------------------------------------

    \31\ 2021 SUSB Annual Data Tables by Establishment Industry, 
<a href="https://www.census.gov/data/tables/2021/econ/susb/2021-susb-annual.html">https://www.census.gov/data/tables/2021/econ/susb/2021-susb-annual.html</a>, accessed: 1/9/2024.
    \32\ Assuming all of the 17 non-registered suppliers are small 
businesses, the percent of small businesses affected by this rule is 
17/8,804 = 0.19%.
---------------------------------------------------------------------------

Unfunded Mandates Reform Act of 1995

    On the basis of information contained in the ``Regulatory 
Flexibility Act'' section above, DEA has determined and certifies 
pursuant to the Unfunded Mandates Reform Act of 1995 (UMRA), 2 U.S.C. 
1501 et seq., that this action would not result in any Federal mandate 
that may result ``in the expenditure by state, local, and tribal 
governments, in the aggregate, or by the private sector, of 
$100,000,000 or more (adjusted for inflation) in any one year . . . .'' 
Therefore, neither a Small Government Agency Plan nor any other action 
is required under provisions of UMRA.

Paperwork Reduction Act of 1995

    This action does not impose a new collection of information 
requirement under the Paperwork Reduction Act of 1995.\33\ This action 
would not impose recordkeeping or reporting requirements on state or 
local governments, individuals, businesses, or organizations. However, 
this rule requires compliance with the following existing OMB 
collections: 1117-0003, 1117-0004, 1117-0006, 1117-0008, 1117-0009, 
1117-0010, 1117-0012, 1117-0014, 1117-0021, 1117-0023, 1117-0029, and 
1117-0056. An agency may not conduct or sponsor, and a person is not 
required to respond to a collection of information unless it displays a 
currently valid OMB control number.
---------------------------------------------------------------------------

    \33\ 44 U.S.C. 3501 through 3521.
---------------------------------------------------------------------------

List of Subjects in 21 CFR Part 1310

    Administrative practice and procedure, Drug traffic control, 
Reporting and recordkeeping requirements.

    For the reasons set out above, DEA amends 21 CFR part 1310 as 
follows:

PART 1310--RECORDS AND REPORTS OF LISTED CHEMICALS AND CERTAIN 
MACHINES; IMPORTATION AND EXPORTATION OF CERTAIN MACHINES

0
1. The authority citation for 21 CFR part 1310 continues to read as 
follows:

    Authority:  21 U.S.C. 802, 827(h), 830, 871(b), 890.


0
2. In Sec.  1310.02, add paragraph (a)(41) to read as follows:


Sec.  1310.02  Substances covered.

* * * * *
    (a) * * *

------------------------------------------------------------------------
 
------------------------------------------------------------------------
 
                                * * * * *
(41) Propionyl chloride.........................................   8337
------------------------------------------------------------------------

* * * * *

0
3. In Sec.  1310.04:
0
a. Redesignate paragraphs (g)(1)(xix) and (g)(1)(xx) as paragraphs 
(g)(1)(xx) and (g)(1)(xxi), respectively; and
0
b. Add new paragraph (g)(1)(xix).
    The addition reads as follows:


Sec.  1310.04  Maintenance of records.

* * * * *
    (g) * * *
    (1) * * *
    (xix) Propionyl chloride
* * * * *

0
4. In Sec.  1310.09, add paragraph (t) to read as follows:


Sec.  1310.09  Temporary exemption from registration.

* * * * *
    (t)(1) Each person required under 21 U.S.C. 822 and 21 U.S.C. 957 
to obtain a registration to manufacture, distribute, import, or export 
propionyl chloride, including regulated chemical mixtures pursuant to 
Sec.  1310.12, is temporarily exempted from the registration 
requirement, provided that DEA receives a properly completed 
application for registration or application for exemption for a 
chemical mixture containing propionyl chloride pursuant to Sec.  
1310.13 on or before 30 days after the publication of a rule finalizing 
this action. The exemption would remain in effect for each person who 
has made such application until the Administration has approved or 
denied that application. This exemption applies only to registration; 
all other chemical control requirements set forth in the Act and parts 
1309, 1310, 1313, and 1316 of this chapter remain in full force and 
effect.
    (2) Any person who manufactures, distributes, imports, or exports a 
chemical mixture containing propionyl chloride whose application for 
exemption is subsequently denied by DEA must obtain a registration with 
DEA. A temporary exemption from the registration requirement will also 
be provided for those persons whose application for exemption is 
denied, provided that DEA receives a properly completed application for 
registration on or before 30 days following the date of official DEA 
notification that the application for exemption has been denied. The 
temporary exemption for such persons would remain in effect until DEA 
takes final action on their registration application.

0
5. In Sec.  1310.12, table in paragraph (c) is amended by adding in 
alphabetical order an entry for ``Propionyl chloride'' to read as 
follows:


Sec.  1310.12  Exempt chemical mixtures.

* * * * *
    (c) * * *

                                          Table of Concentration Limits
----------------------------------------------------------------------------------------------------------------
                                             DEA
                                           chemical         Concentration               Special conditions
                                           code No.
----------------------------------------------------------------------------------------------------------------
                                                List I Chemicals
----------------------------------------------------------------------------------------------------------------
 
                                                  * * * * * * *
Propionyl chloride......................       8337  Not exempt at any           Chemical mixtures containing
                                                      concentration.              any amount of propionyl
                                                                                  chloride are not exempt.
 

[[Page 11456]]

 
                                                  * * * * * * *
----------------------------------------------------------------------------------------------------------------

* * * * *

Signing Authority

    This document of the Drug Enforcement Administration was signed on 
February 25, 2026, by Administrator Terrance C. Cole. That document 
with the original signature and date is maintained by DEA. For 
administrative purposes only, and in compliance with requirements of 
the Office of the Federal Register, the undersigned DEA Federal 
Register Liaison Officer has been authorized to sign and submit the 
document in electronic format for publication, as an official document 
of DEA. This administrative process in no way alters the legal effect 
of this document upon publication in the Federal Register.

Heather Achbach,
Federal Register Liaison Officer, Drug Enforcement Administration.
[FR Doc. 2026-04657 Filed 3-9-26; 8:45 am]
BILLING CODE 4410-09-P


</pre></body>
</html>
Indexed from Federal Register on March 10, 2026.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.